Antibe Therapeutics Inc(Pre-Merger) T.ATE

Here's an OA drug-failed P2 and misses out on $250M USD

[MrMugsy]

I guess it was a high risk venture and failed.

https://www.fiercebiotech.com/biotech/galapagos-osteoarthritis-drug-flunks-phase-2-dashing-hopes-250m-gilead-deal

[bringon10bagger]

I guess Antibe's pipeline has some value.......quote from article....With Gilead paying $5 billion upfront to secure broad access to Galapagos’ pipeline,

[TriumphSpitSix]

A $5B USD deal for Antibe's pipeline (each with more promise than any of Galapagos' dogs combined) would put us just under $13 ($17 CAD) per share based on current OS. File under "Life-changing Financial Events."

[MrMugsy]

Exactly. Antibe has ONE opportunity here to get it exactly right - to come to the negotiating table with all the facts and all the comparables. That takes a little time. What I like is ... we're talking about a blockbuster opportunity and it isn't like we're trying to solve a new disease or condition.  We have a family of drugs to fix longstanding problems.  It either does